Musculoskeletal disorders such as osteoporosis, osteoarthritis or sarcopenia are affecting an ever greater proportion of the world's population – with disability due to these conditions having increased by 45% from 1990 to 2010 alone. The focus of the world's leading medical and research congress in the musculoskeletal field, which opens today in Malaga, Spain, will be on new ways in which to prevent and manage these serous and disabling conditions.
The World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016) is hosted by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Professor Jean-Yves Reginster, ESCEO President and Congress Co-Chair, stated, "The WCO-IOF-ESCEO annual congress is the must-attend research and educational forum for the broad range of clinicians and researchers who are active in the bone, muscle and joint arena. This year we were especially pleased to receive more than 1150 abstracts – a record number which testifies to the Congress' status as the leading global venue for the presentation of clinical research findings. The quality of the abstracts was exceptionally high and delegates can look forward to hearing about some exciting new research findings."
The scientific programme covers a wide scope of important topics presented in: 10 plenary lectures by renowned speakers, 51 oral communications selected from outstanding abstracts, and 20 oral presentations of selected posters. Specific topics will be addressed in 15 different Meet-The-Expert sessions and nine special sessions and symposia on issues of clinical importance. In addition to scheduled poster sessions, there will be six industry sponsored satellite symposia and 16 non-sponsored topical symposia that cover a broad range of 'hot' topics and clinically-relevant advances.
IOF President and Congress Co-Chair, Professor John A. Kanis said, "We look forward to an exciting programme which will present important new findings that will help advance our knowledge of musculoskeletal diseases. The multidisciplinary programme will help build bridges of knowledge between the various disciplines and between translational research and patient care."
The abstracts presented at WCO-IOF-ESCEO 2016 have been published in Volume 27/Suppl 1/ 2016 of the leading journal Osteoporosis International.
Read more about the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, taking place at the Palacio de Ferias y Congresos de Málaga (FYCMA) until April 17, 2016: http://www.wco-iof-esceo.org
About World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016):
Held jointly by IOF and ESCEO, the Congress is taking place in Malaga, Spain from April 14-17,2016. It is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. The next Congress will be held in Florence, Italy from March 23-26, 2017. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth